Myotonic syndrome

Myotonic syndrome (Orphanet code 206970) is a clinical grouping term that encompasses a set of conditions characterized by myotonia — the inability of muscles to relax normally after voluntary contraction or stimulation. Myotonia results from abnormal electrical excitability of the muscle cell membrane, typically due to dysfunction of skeletal muscle ion channels (chloride or sodium channels). Patients experience muscle stiffness, difficulty releasing grip, and delayed relaxation of muscles after use. The stiffness often improves with repeated movement, a phenomenon known as the "warm-up" effect. Myotonia primarily affects skeletal muscles, including those of the hands, legs, face, and eyelids, and can impair daily activities such as walking, climbing stairs, or handling objects. Myotonic syndrome is not a single disease entity but rather a clinical phenotype that can be seen in several distinct genetic disorders, including myotonic dystrophy type 1 (DM1, Steinert disease), myotonic dystrophy type 2 (DM2/PROMM), myotonia congenita (Thomsen and Becker forms), paramyotonia congenita, and sodium channel myotonias. The underlying genetic causes and inheritance patterns vary depending on the specific condition. Diagnosis typically involves clinical examination, electromyography (EMG) showing characteristic myotonic discharges, and genetic testing to identify the specific causative mutation. Treatment of myotonic syndrome is primarily symptomatic. Medications such as mexiletine (a sodium channel blocker) are commonly used to reduce myotonia and improve muscle relaxation. Other agents that may be considered include carbamazepine, phenytoin, or lamotrigine. Physical therapy and avoidance of triggers such as cold exposure or prolonged immobility can also help manage symptoms. The prognosis depends on the underlying condition; isolated myotonia (as in myotonia congenita) generally has a favorable outlook, while myotonic dystrophies may involve progressive multisystem involvement including cardiac, respiratory, endocrine, and central nervous system complications.

Common questions about Myotonic syndrome